Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Michael Higgins has joined the Company’s board of directors.
“We are delighted to welcome Michael to our Board,” said Chip Clark, president and chief executive officer of Genocea. “Michael’s experience in helping to guide Ironwood Pharmaceuticals from development through to commercialization will be invaluable to Genocea as we continue to advance our strong portfolio of clinical and research stage programs.”
Help employers find you! Check out all the jobs and post your resume.
